11 Aug 2025 Date | | - Cons. EPS | - EPS |
28 May 2025 Date | | - Cons. EPS | - EPS |
26 Feb 2025 Date | | - Cons. EPS | - EPS |
26 Aug 2024 Date | | - Cons. EPS | - EPS |
23 Jan 2024 Date | | - Cons. EPS | - EPS |
11 Aug 2025 Date | | - Cons. EPS | - EPS |
28 May 2025 Date | | - Cons. EPS | - EPS |
26 Feb 2025 Date | | - Cons. EPS | - EPS |
26 Aug 2024 Date | | - Cons. EPS | - EPS |
23 Jan 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Todd A. Davis CEO | OTC PINK Exchange | 29259K102 Cusip |
US Country | 10 Employees | - Last Dividend | - Last Split | - IPO Date |
Endexx Corporation is a prominent name in the health and wellness industry, focusing on the production and distribution of cannabidiol (CBD)-based products. The company aims to deliver natural solutions for pain and inflammation relief among humans and pets. Originating as CBD Unlimited, Inc., it underwent a rebranding to Endexx Corporation in May 2020, showcasing its broadened vision and commitment to excellence. Headquartered in Cave Creek, Arizona, Endexx leverages its online platform, cbdunlimited.com, alongside other digital and brick-and-mortar retail avenues, to reach its diverse clientele.